REVANESSE PURE

REVANESSE PURE is a gel:
- Colourless, odourless transparent and watery, of synthetic origin.
- Contains high-purity non-crosslinked hyaluronic acid, indicated for deep skin hydration and treatment of fine wrinkles.
- A water-based and fully biocompatible formulation, ensuring uniform integration into tissues without marked volumising effects.
- Produced with advanced purification technology, which minimises bacterial proteins and other impurities, improving skin tolerance and safety.

- PROLLENIUM MEDICAL TECHNOLOGIES INC.
- NAME: REVANESSE PURE
- COMPOSITION: Hyaluronic acid 14mg/ml.
- PRESENTATION: 2 x 1.2 ml.
- NEEDLES: 2 x 30G.
- INDICATIONS: Revanesse® Pure is a hyaluronic acid gel indicated for the treatment of facial wrinkles and lipoatrophy by injection into the skin.
- INJECTION DEPTH: Superficial dermis.
- DURATION: 6 to 9 months.
- USE: Strict medical use.

- Syringe: 2 x 1.2 ml.
- Needles: 2 x 30G.

Facial wrinkles, neck, décolleté and hands.

Hyaluronic acid 14mg/ml.

- Revanesse® Pure should not be injected into an area that already contains another filler product as there are no clinical data regarding possible reactions.
- Revanesse® Pure should not be injected into an area where a permanent filler or implant exists.
- Hyaluronic acid products have a known incompatibility with quaternary ammonium salts such as benzalkonium chloride. Ensure that Revanesse® Pure does not come into contact with this substance or with medical instruments that have been in contact with it.
- Revanesse® Pure must never be used for breast augmentation or implants in bone, tendon, ligament or muscle.
- Avoid touching the treated area for 12 hours after injection and avoid prolonged exposure to sunlight, UV light and extreme heat or cold.
- Until the initial swelling and redness has resolved, do not expose the treated area to intense heat (e.g. solarium or sun exposure) or extreme cold.
- If one has previously suffered from simple herpes in the facial area, there is a risk that needle injections will contribute to another herpes simplex eruption.
- Keep in mind that the use of aspirin, non-steroid anti-inflammatory drugs, St. John's Wort extracts, high-dose vitamin E supplements, or similar drugs prior to treatment may increase bruising and bleeding at the injection site.
- In order to minimise the risk of potential complications, this product should only be used by healthcare personnel with specific training and experience and knowledge of the anatomy relating to the injection site.
- Healthcare professionals are advised to communicate all potential risks of soft tissue injection to their patients prior to treatment and ensure that patients do not present signs and symptoms of potential complications.

REVANESSE PURE is contraindicated in the following cases:
- Do not inject Revanesse® Pure around the eyes (periocular area or eyelids).
- Pregnant or lactating women should not be treated with Revanesse® Pure.
- Revanesse® Pure is only intended for intradermal use and must not be injected into blood vessels. This could occlude them and cause an embolism.
- Patients who develop hypertrophic scars should not be treated with Revanesse® Pure.
- Patients with a known history of streptococcal infection.
- Never use Revanesse® Pure with a laser, intense pulsating light, chemical peeling or dermabrasion treatments.
- Do not treat patients under 18 years of age with Revanesse® Pure.
- Patients with acne and/or other inflammatory skin diseases should not be treated with Revanesse® Pure.
- Treatment is not indicated for patients with unrealistic expectations.
- Patients with multiple severe allergies.
- Patients with acute or chronic skin diseases at or near the injection site.
- Patients with coagulation disorders or undergoing anti-coagulation therapy.
- Patients suffering from sensitivity to hyaluronic acid.

Indicated for the treatment of fine and superficial wrinkles, deep skin hydration, correction of small furrows and depressions, prevention of the initial signs of ageing and slight shaping of facial contours.